Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
About This Item
Linear Formula:
C2H5OCH2CH2OCH2CH2OH
CAS Number:
Molecular Weight:
134.17
EC Number:
203-919-7
UNSPSC Code:
12352112
PubChem Substance ID:
Beilstein/REAXYS Number:
1736441
MDL number:
grade
SAJ first grade
vapor density
4.63 (vs air)
vapor pressure
0.12 mmHg ( 20 °C)
assay
≥98.0%
form
liquid
expl. lim.
1.2 %, 135 °F, 23.5 %, 182 °F
availability
available only in Japan
refractive index
n20/D 1.427 (lit.)
bp
202 °C (lit.)
density
0.999 g/mL at 25 °C (lit.)
SMILES string
CCOCCOCCO
InChI
1S/C6H14O3/c1-2-8-5-6-9-4-3-7/h7H,2-6H2,1H3
InChI key
XXJWXESWEXIICW-UHFFFAOYSA-N
Legal Information
CARBITOL is a trademark of The Dow Chemical Company or an affiliated company of Dow
Still not finding the right product?
Explore all of our products under Diethylene glycol monoethyl ether
Storage Class
10 - Combustible liquids
wgk
WGK 1
flash_point_f
204.8 °F - closed cup
flash_point_c
96 °C - closed cup
ppe
Eyeshields, Gloves, multi-purpose combination respirator cartridge (US)
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Simona Mura et al.
Journal of drug targeting, 19(3), 189-196 (2010-05-08)
The aim of this work was to evaluate the ability of Transcutol (Trc) to produce elastic vesicles with soy lecithin (SL) and study the influence of the obtained vesicles on in vitro (trans)dermal delivery of minoxidil. To this purpose, so-called
Hyun-Jong Cho et al.
International journal of pharmaceutics, 423(2), 153-160 (2012-01-03)
To achieve rapid onset of action and improved bioavailability of udenafil, a microemulsion system was developed for its intranasal delivery. Phase behavior, particle size, transmission electron microscope (TEM) images, and the drug solubilization capacity of the microemulsion were investigated. A
Bhupinder Singh et al.
Drug delivery, 18(8), 599-612 (2011-10-20)
Carvedilol, a widely prescribed cardiovascular drug for hypertension and congestive heart failure, exhibits low and variable bioavailability owing to poor absorption and extensive hepatic first-pass metabolism. The current research work, therefore, entails formulation development of liquid self-nano-emulsifying drug delivery systems